Navigation Links
Study finds an increase of children accidentally poisoned with pharmaceuticals
Date:9/15/2011

Cincinnati, OH, September 16, 2011 -- Pharmaceutical poisoning remains a common childhood injury, despite years of concerted prevention efforts, such as improved safe guards on packaging. Over half a million children are exposed to pharmaceuticals each year. A new study soon to be published in The Journal of Pediatrics attempts to understand this growing problem to aid in the progress of reducing the number of childhood injuries due to pharmaceutical poisoning.

Dr. Randall Bond and colleagues from Cincinnati Children's Hospital Medical Center and the University of Cincinnati gathered information about 544,133 children 5 years of age and younger who had visited the emergency department (ED) because they may have been poisoned by medication. The data was gathered from all cases reported to the American Association of Poison Control Centers between 2001 and 2008. In an attempt to find a focus for continued poison prevention methods, the authors organized the data according to medication type and whether the exposure was caused by the child self-ingesting the medication or by a dosing error.

"We need to know the medications and ingestion circumstances that contribute most to ED visits, hospitalization, and harm," Dr. Bond explains. The authors found that 95% of ED visits resulted from self-ingestion. Prescription drugs accounted for 55% of the ED visits, 76% of hospital admissions, and 71% of significant injuries. The biggest impact came from opioid-containing pain medications (eg, oxycodone, morphine, codeine), sedative hypnotics (eg, muscle relaxants, sleep aids), and cardiovascular medications. "The problem of pediatric poisoning in the U.S. is getting worse, not better," Dr. Bond asserts. Overall, there was a 22% increase in the exposure for this age group, although the number of children in the U.S. under the age of 5 years increased only 8% during the study period.

The authors attribute this increase to a greater availability of, and access to, medications in the child's home. They also note that effective "poison proofing" may have plateaued or declined in recent years. "Prevention efforts of parents and caregivers to store medicines in locked cabinets or up and away from children continue to be crucial. However, the largest potential benefit would come from packaging design changes that reduce the quantity a child could quickly and easily access in a self-ingestion episode, like flow restrictors on liquids and one-at-a-time tablet dispensing containers," Dr. Bond suggests. He goes on to recommend that such changes should be applied to both adult and pediatric products and to over-the-counter and prescription products.


'/>"/>

Contact: Brigid Huey
journal.pediatrics@cchmc.org
513-636-7140
Elsevier Health Sciences
Source:Eurekalert

Related biology news :

1. UF-led study: Invasive amphibians, reptiles in Florida outnumber world
2. Voting causes stress according to Ben-Gurion University of the Negev study
3. Gene flux can foretell survival for trauma patients, Princeton study finds
4. SDSC-developed software used in first global camera trap mammal study
5. Study finds chronic abnormal brain blood flow in Gulf War veterans
6. Study reveals critical similarity between two types of do-it-all stem cells
7. International study identifies new gene targets for hypertension treatment
8. BMC awarded NIH grant to study brain abnormalities in former ELGANS patients
9. Study in Tanzania finds fishery improvements outweigh fuelwood losses
10. University of Tennessee chosen to join national network to study climate change
11. Endangered horse has ancient origins and high genetic diversity, new study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... February 7, 2017 Ipsidy Inc. ... Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a provider ... processing services, is pleased to announce the following changes ... Effective January 31, 2017, Philip D. Beck ... CEO and President.  An experienced payment industry professional and ...
(Date:2/3/2017)... ANTONIO , Feb. 3, 2017  Texas Biomedical Research ... Dr. Larry Schlesinger as the Institute,s new ... Texas Biomed effective May 31, 2017. He is currently the ... Director of the Center for Microbial Interface Biology at Ohio ... Schlesinger as the new President and CEO of Texas Biomed," ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: ... February 24, 2017 a total of 10,672,750 common share purchase ... common share. Proceeds from the exercise of these warrants totalled ... ... are grateful for this expression of confidence by our warrant ...
(Date:2/27/2017)... YORK , February 27, 2017 ... by Stock-Callers.com for evaluation today, and they are: Anthera ... Pacific Biosciences of California Inc. (NASDAQ: PACB), and Conatus ... an article on ETF Trends, market observers are growing ... and administration could enact reforms to free cash held ...
(Date:2/27/2017)... FRANCISCO , Feb. 27, 2017 Fluxion ... Spain has been appointed as a ... System. The IsoFlux system will be used in Genetracer ... relevant to lung and colon cancer, with plans to ... The laboratory is utilizing Fluxion,s IsoFlux System to isolate, ...
(Date:2/27/2017)... ... February 27, 2017 , ... The Catalyst Midwest premix manufacturing facility ... offering premix services and private label organic services. , The first organic product is ... chief operating officer of Dynamite Marketing, which owns the facility. , Catalyst already has ...
Breaking Biology Technology: